Renee P Tannenbaum Ani Pharmaceuticals Inc (ANIP) insider trading activity

Renee P Tannenbaum is Director of ANI PHARMACEUTICALS INC. Currently has a direct ownership of 22,621 shares of ANIP, which is worth approximately $1.3 Million. The most recent transaction as insider was on May 21, 2024, when has been sold 4,410 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.6K

0% 3M change

11.92% 12M change

Total Value Held $1.3 Million

RENEE P TANNENBAUM Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 21 2024	BUY Grant, award, or other acquisition	-	4,410 Added 16.31%	22,621 Common Stock
May 16 2024	SELL Open market or private sale	$127,740 $63.87 p/Share	2,000 Reduced 9.9%	18,211 Common Stock
May 23 2023	BUY Grant, award, or other acquisition	-	6,865 Added 25.35%	20,211 Common Stock
Mar 19 2022	BUY Grant, award, or other acquisition	-	13,346 Added 50.0%	13,346 Common Stock

Also insider at

ZGNX

ZOGENIX, INC.

Director

CRDF

Cardiff Oncology, Inc. Healthcare

Director

RPT